# Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Study · id `cardio:ct-nct04240444` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04240444](<https://clinicaltrials.gov/study/NCT04240444>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04240444

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 260 participants.

## Technical summary

Registry record NCT04240444. Randomized; single masking; primary purpose treatment. Start 2020-10-10 (actual); primary completion 2022-07-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 260 participants (enrolled count; ClinicalTrials.gov record NCT04240444, source copy `cardio:ctgov-nct04240444-2023-11-14`, retrieved 2026-10-26)
- Started: 2020-10-10 (actual) (ClinicalTrials.gov record NCT04240444, source copy `cardio:ctgov-nct04240444-2023-11-14`, retrieved 2026-10-26)
- Primary completion: 2022-07-26 (actual) (ClinicalTrials.gov record NCT04240444, source copy `cardio:ctgov-nct04240444-2023-11-14`, retrieved 2026-10-26)
- Completion: 2022-08-30 (actual) (ClinicalTrials.gov record NCT04240444, source copy `cardio:ctgov-nct04240444-2023-11-14`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04240444, source copy `cardio:ctgov-nct04240444-2023-11-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04240444-2023-11-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis
- Acronym: SIBLINT ISR
- Condition: Coronary Artery Disease
- Condition: In Stent Restenosis
- Intervention (Device): drug-coated balloon Catheter
- Lead sponsor: B. Braun Medical International Trading Company Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: CCRF Inc., Beijing, China
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: B. Braun Medical International Trading Company Ltd. (`cardio:org-b-braun-medical-international-trading-company-ltd`)
- Registry lists this organization as a collaborator: CCRF Inc., Beijing, China (`cardio:org-ccrf-inc-beijing-china`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis: The SIBLINT-ISR Randomized Trial (`cardio:pubmed-39985511`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8e2c98b0fd96108a7f1d46101ffb16751e217ae2fd63147e58ce3fdf0914ccfe
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
